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Hemangiomas and vascular malformations constitute a variety of non-cancerous birthmarks and lesions.
We experienced a rare case of a fetus with a giant congenital hemangioma detected on the fetal ultra-
sonography and magnetic resonance imaging (MRI). The patient was delivered via a planned cesarean
section and underwent extirpation of the tumor on the 16th postnatal day due to concerns of bleeding
from the tumor. A pathological examination demonstrated glucose transporter (GLUT)-1-negative
lobular capillary proliferation compatible with a diagnosis of congenital hemangioma. The infant was
discharged without complications on day 14 after tumor resection. Currently, at 5 years of age, no tumor
recurrence has so far been observed since the extirpation. The antenatal images of this case are presented
and the perinatal management is discussed.
 2013 Elsevier Inc. Open access under CC BY-NC-ND license. Congenital hemangiomas (CHs) are fully formed at birth, having
undergone proliferation in utero, do not exhibit the typical post-
natal evolutive pattern of infantile hemangioma (IH) and can be
diagnosed prenatally using ultrasonography [1]. CH is a subtype of
benign vascular tumor, that is further characterized as either
rapidly involuting (RICH) or non-involuting (NICH). In most infants
with RICH, involution is complete, leaving anetodermic skin within
6e14 months of life, whereas NICH lesions grow proportionally
with the child’s growth. NICHs never disappear and therefore
require eventual excision. However, when CH is prenatally detected
and there are concerns of bleeding or heart failure due to the high
blood ﬂow of the tumor, surgical resection may be performed
immediately after birth.
We herein report a rare case of a fetus with a giant congenital
hemangioma detected on the fetal ultrasonography and magnetic
resonance imaging (MRI) that was treated with surgical resection.
1. Case report
A 29-year-old female was referred at 29 weeks of gestation due
to an ultrasonographically detected tumor located on the fetal
posterior neck. Ultrasonography revealed a 65  67  43-mmery, Department of Surgery,
2 Yamadaoka, Suita, Osaka
79 3759.
(S. Uehara).
-NC-ND license. heterogeneous tumor that made contact with the infant’s spine and
skull (Fig. 1A). Color Doppler imaging revealed rich vascular
formation and blood ﬂow in the tumor. T2-weighted images of
magnetic resonance imaging (MRI) obtained at 34 weeks of gesta-
tion revealed iso-high signal intensity (Fig. 1B). These ﬁndings were
compatible with a diagnosis of hemangioma. During the pregnancy,
fetal echography showed no increases tumor size; however, a mild
right heart load was detected.
At 38 weeks of gestation, a planned cesarean section was per-
formed with appropriate informed consent to prevent dystocia and
bleeding from the tumor during vaginal delivery. A 2622-g-male
infant was delivered with Apgar scores of 8 and 9 at one and 5 min,
respectively. The infant did not require resuscitation or respiratory
support. The tumor originated from the posterior of the neck, as
observed on prenatal images. The color of the tumor became more
red with each passing day, and the surface of the tumor gradually
demonstrated enlargement, creating an ulcer on the surface of the
tumor (Fig. 2). No signs of involution of the tumor were observed
until the 15th postnatal day. Since the tumor appeared ready to
bleed from the surface, tumor resection was performed on the 16th
postnatal day. First, a spindle-shaped skin incision was made
around the tumor. Tumor mobilization was achieved with ﬁne
ligations of the vessels in the subcutanous lesion, preserving the
posterior neck muscles. The tumor was successfully resected
completely. Skin grafting was not required to close the wound. The
amount of blood loss was 132 ml, and the operative time was 3 h
and 13 min. A pathological examination revealed lobular capillary
Fig. 1. Prenatal images of color Doppler ultrasonography at 29 weeks of gestation showing the 65  67 43-mm heterogeneous tumor that made contact with the infant’s spine and
skull. Rich vascular formation and blood ﬂow in the tumor was observed (A). T2-weighted images of magnetic resonance imaging (MRI) obtained at 34 weeks of gestation revealed
iso-high signal intensity (B).
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endothelial cells, in contrast to the positive ﬁndings in red blood
cells observed in the vessels as an internal control of GLUT-1
(Fig. 3B), compatible with a diagnosis of congenital hemangioma.
The infant was discharged without complications on day 14 after
tumor resection. Currently, at age 5 years of age, no tumor recur-
rence has not been observed since the tumor resection.
2. Discussion
The concept of a classiﬁcation system for pediatric vascular
anomalies was ﬁrst established in 1982 based on the pathologic
ﬁndings reported in a study by Mulliken and Glowacki and later
modiﬁed by the International Society for the Study Group of
Vascular Anomalies [2]. Congenital hemangioma (CH) is a subtype
of benign vascular tumor that is further characterized as rapidly
involuting (RICH) or non-involuting (NICH). Infantile hemangioma
(IH) and CH are distinguished based on their clinical features and
the presence of a GLUT-1-positive expression in the endothelialFig. 2. Postnatal photograph showing the neonate with a tumor on the posterior neck.cells of infantile hemangioma (IH) [3]. The involution observed in
cases of RICH is very similar to that observed in cases of IH, which
regresses slowly after occurring during the ﬁrst year of life [4]. In
contrast, NICH does not exhibit the regression. Consequently, the
possibility of NICH being a later stage of RICH has been suggested.
Therefore, to determine the fate of RICH and NICH, monitoring for
an observation period of a few years and performing serial post-
natal imaging can provide insight into imaging evolution and
involution of RICH during the ﬁrst year of life.
Both CH and IH appear as fast-ﬂow lesions on ultrasound and
exhibit ﬂow voids on MRI. RICH and NICH are more likely to be
heterogeneous on US and much more likely to contain identiﬁable
calciﬁcation. On MRI, these lesions exhibit high intensity on T2-
weighted images and iso-intensity on T1-weighted images; prior to
involution, they enhance avidly and homozygously [5]. Fast-ﬂow is
also detected in arterial vascular malformations; however, it can be
easily differentiated on MRI. Prenatal screening with ultrasonog-
raphy allows for the early detection of CH as early as 12 weeks of
gestation [4]. A distinction between RICH and NICH lesions cannot
be made on prenatal ultrasound [6]. If CH is diagnosed antenatally,
the lesion can be followed on ultrasonography and MRI to further
deﬁne the tumor characteristics and monitor growth [7].
In our case, immunohistochemical staining revealed negative
GLUT-1 results, suggesting a diagnosis of CH. However, it is difﬁcult
to distinguish RICH from NICH before and at birth without the
knowledge obtained from histological ﬁndings and observation for
at least one year. Since the tumor in our casewas likely to be injured
by mechanical friction, we believed that it should be excised
without observation to distinguish involution.
As Nolan et al. [8] previously reported, life-threatening hemor-
rhage associated with passage through the birth canal can result in
by birth trauma if the tumor is large and located on the surface of
the neonate. In such cases, cesarean section should be used for
delivery. Bleeding may also occur, even after birth, due to
mechanical friction. Powell et al. [9] reported that two cases of
severe bleeding episodes occurred during the ﬁrst week of life.
Close antenatal evaluation, including the frequent use of US to
monitor lesion size and blood ﬂow, should be conducted. Large
hemangiomas can cause congestive heart failure due to hyper-
dynamic circulation leading to increasing cardiac output; therefore,
fetal circulatory parameters should also be monitored. When these
ﬁndings are observed, surgical excision should be considered
Fig. 3. Microscopic examination showing capillaries and feeding vessels with ﬂattened endothelial cells on hematoxylin eosin staining (A, 200). GLUT-1 immunostaining was
negative (B, 200), consistent with a diagnosis of congenital hemangioma.
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should be close observation.3. Conclusion
We herein reported a rare case of a fetus with a giant congenital
hemangioma detected on the fetal ultrasonography and MRI that
was treated with the extirpation. Close follow-up before and after
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